172 related articles for article (PubMed ID: 35445333)
1. Pregnancy may have little influence on ground-glass opacities suspected for lung adenocarcinoma.
Bai J; Deng C; Fu F; Li D; Ma Z; Ma X; Zhang Y; Chen H
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1383-1389. PubMed ID: 35445333
[TBL] [Abstract][Full Text] [Related]
2. Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy.
Zhang Y; Deng C; Ma X; Gao Z; Wang S; Zheng Q; Xia G; Wen Z; Han H; Fu F; Liu Q; Hu H; Li Y; Wong KK; Chen H
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2411-2417. PubMed ID: 32356178
[TBL] [Abstract][Full Text] [Related]
3. Surgical Management of Multifocal Ground-Glass Opacities of the Lung: Correlation of Clinicopathologic and Radiologic Findings.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Thorac Cardiovasc Surg; 2017 Mar; 65(2):142-149. PubMed ID: 26902328
[No Abstract] [Full Text] [Related]
4. A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease.
Gu B; Burt BM; Merritt RE; Stephanie S; Nair V; Hoang CD; Shrager JB
Ann Thorac Surg; 2013 Aug; 96(2):411-8. PubMed ID: 23806231
[TBL] [Abstract][Full Text] [Related]
5. Management of Ground-Glass Opacities in the Lung Cancer Spectrum.
Zhang Y; Fu F; Chen H
Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031
[TBL] [Abstract][Full Text] [Related]
6. A computerized tomography-based radiomic model for assessing the invasiveness of lung adenocarcinoma manifesting as ground-glass opacity nodules.
Zhu M; Yang Z; Wang M; Zhao W; Zhu Q; Shi W; Yu H; Liang Z; Chen L
Respir Res; 2022 Apr; 23(1):96. PubMed ID: 35429974
[TBL] [Abstract][Full Text] [Related]
7. Invasiveness and malignant potential of pulmonary lesions presenting as pure ground-glass opacities.
Ichinose J; Kohno T; Fujimori S; Harano T; Suzuki S; Fujii T
Ann Thorac Cardiovasc Surg; 2014; 20(5):347-52. PubMed ID: 24088912
[TBL] [Abstract][Full Text] [Related]
8. The long-term course of ground-glass opacities detected on thin-section computed tomography.
Lee SW; Leem CS; Kim TJ; Lee KW; Chung JH; Jheon S; Lee JH; Lee CT
Respir Med; 2013 Jun; 107(6):904-10. PubMed ID: 23514949
[TBL] [Abstract][Full Text] [Related]
9. Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma.
Gao RW; Berry MF; Kunder CA; Khuong AA; Wakelee H; Neal JW; Backhus LM; Shrager JB
J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2092-2099.e2. PubMed ID: 28863952
[TBL] [Abstract][Full Text] [Related]
10. The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma.
Murakawa T; Konoeda C; Ito T; Inoue Y; Sano A; Nagayama K; Nakajima J
Eur J Cardiothorac Surg; 2013 May; 43(5):925-32. PubMed ID: 23047267
[TBL] [Abstract][Full Text] [Related]
11. Partly solid pulmonary nodules: waiting for change or surgery outright?
Seok Y; Cho S; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):556-60. PubMed ID: 24981106
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.
Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
Wang Y; Jing L; Wang G
J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
[TBL] [Abstract][Full Text] [Related]
14. Surgical outcomes in lung cancer presenting as ground-glass opacities of 3 cm or less: a review of 5 years' experience.
Duann CW; Hung JJ; Hsu PK; Huang CS; Hsieh CC; Hsu HS; Wu YC; Hsu WH
J Chin Med Assoc; 2013 Dec; 76(12):693-7. PubMed ID: 24099986
[TBL] [Abstract][Full Text] [Related]
15. Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer.
Shewale JB; Nelson DB; Rice DC; Sepesi B; Hofstetter WL; Mehran RJ; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Antonoff MB
Ann Thorac Surg; 2018 Jun; 105(6):1671-1677. PubMed ID: 29432718
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of resected solitary ground-glass opacities: Comparison between benign and malignant nodules.
Qin Y; Xu Y; Ma D; Tian Z; Huang C; Zhou X; He J; Liu L; Guo C; Wang G; Zhang J; Wang Y; Liu H
Thorac Cancer; 2020 Oct; 11(10):2767-2774. PubMed ID: 32844603
[TBL] [Abstract][Full Text] [Related]
17. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
[TBL] [Abstract][Full Text] [Related]
18. Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?
Kobayashi Y; Mitsudomi T
Transl Lung Cancer Res; 2013 Oct; 2(5):354-63. PubMed ID: 25806254
[TBL] [Abstract][Full Text] [Related]
19. Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features presenting as ground-glass opacities on CT.
Mirtcheva RM; Vazquez M; Yankelevitz DF; Henschke CI
Clin Imaging; 2002; 26(2):95-100. PubMed ID: 11852215
[TBL] [Abstract][Full Text] [Related]
20. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
